Facilitating DCT with DtP Trial Strategy

Facilitating DCT with DtP Trial Strategy
June 13, 2022 YPrime

A direct-to-patient (DtP) clinical trial design, where investigational medicinal products (IMP) and clinical supplies are shipped or delivered directly to patients, fits within a decentralized clinical trial (DCT) model. Although patients, sites, and sponsors can all benefit from this trial design, there are unique complexities to DtP trials, that can be managed with advanced technology. In this podcast, Jon Paras talks about this trial strategy, the unique challenges, what the industry is doing to address these challenges and how technology can help facilitate adoption of this trial design.

Listen to the podcast to learn more about why a sponsor would want to adopt a direct-to-patient clinical trial strategy and the benefit to patients.

PODCAST

Facilitating DCT with DtP Trial Strategy

Jon Paras

RELATED CONTENT

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

Importance of Seeking Patient Insights to Develop Effective Decentralized Clinical Trial Strategies

Importance of Seeking Patient Insights to Develop Effective Decentralized Clinical Trial Strategies

Facilitating DCT with DtP Trial Strategy

Facilitating DCT with DtP Trial Strategy

LATEST CONTENT

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

Put the power in the hands of patients with YPrime eConsent

Put the power in the hands of patients with YPrime eConsent

YPrime Launches eConsent Solution